Zelda’s Share Price Spikes 2.94% on Friday after Insomnia Trial Commencement

Over the last week, Zelda's share price has been travelling quite irregularly, but on Friday its shares spiked by 2.94%, only to loose ground today trading a little lower at $0.069. Zelda Therapeutics Ltd [ASX:ZLD] is a company that uses medicinal cannabis for the treatment of various medical conditions. With a research focus based on pre-clinical trials in cancers such as breast, brain and pancreatic, with clinical trials in autism, eczema and insomnia.

Zelda Therapeutics Share Price Up 2.27%

Shares of Zelda Therapeutics Ltd [ASX:ZLD] climbed over 2% in today’s first half hour of trading. Shares are trading at $0.090 at the time of writing, a 2.27% rise for the day. The company brings together leading researchers and clinicians in the study of medical cannabis.
Money Morning Australia